Scarica l'app Stockscreener
7.80
1.89%
-0.15
Dopo l'orario di chiusura:
7.84
0.04
+0.51%
Precedente Chiudi:
$7.95
Aprire:
$8.01
Volume 24 ore:
27,946
Relative Volume:
0.04
Capitalizzazione di mercato:
$10.34M
Reddito:
$1.47M
Utile/perdita netta:
$-97.61M
Rapporto P/E:
-5.2349
EPS:
-1.49
Flusso di cassa netto:
$-80.90M
1 W Prestazione:
-4.29%
1M Prestazione:
-14.38%
6M Prestazione:
-14.71%
1 anno Prestazione:
-49.28%
Intervallo 1D:
$7.6335
$8.3685
Intervallo di 1 settimana:
$7.6335
$8.6699
Portata 52W:
$3.8101
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Nome
Lyra Therapeutics Inc
Settore
Industria
Telefono
617-373-4600
Indirizzo
480 ARSENAL WAY, WATERTOWN, MA
Confronta LYRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
7.80 | 12.71M | 1.47M | -97.61M | -80.90M | -1.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-07 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-05-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-05-06 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | Ripresa | BTIG Research | Buy |
| 2023-08-31 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-26 | Iniziato | BTIG Research | Buy |
| 2020-05-26 | Iniziato | BofA/Merrill | Buy |
| 2020-05-26 | Iniziato | Jefferies | Buy |
| 2020-05-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie
Is it time to cut losses on Lyra Therapeutics Inc.Buy Strategy with Smart Exit Timing - Newser
Should you wait for a breakout in Lyra Therapeutics Inc.Free AI Powered High Return Stock Calls - Newser
What makes Lyra Therapeutics Inc. stock price move sharplyBreakneck growth rates - jammulinksnews.com
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionFree Capital Protection Trading Strategies - Newser
Is Lyra Therapeutics Inc. stock overvalued or undervaluedDiscover high-impact stocks for growth - jammulinksnews.com
What are the latest earnings results for Lyra Therapeutics Inc.Achieve unparalleled market performance - jammulinksnews.com
Why is Lyra Therapeutics Inc. stock attracting strong analyst attentionFree Predictions - jammulinksnews.com
What is the dividend policy of Lyra Therapeutics Inc. stockCapitalize on emerging trends for profits - jammulinksnews.com
How many analysts rate Lyra Therapeutics Inc. as a “Buy”Invest in stocks with strong fundamentals - jammulinksnews.com
What catalysts could drive Lyra Therapeutics Inc. stock higher in 2025Outstanding capital appreciation - jammulinksnews.com
How does Lyra Therapeutics Inc. compare to its industry peersGet expert insights on market-moving stocks - jammulinksnews.com
Will Lyra Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsProfitable Yet Secure Picks - Newser
How Interest Rate Changes Impact Lyra Therapeutics Inc. Stock PerformanceChart Based Entries - Newser
Lyra Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayDefensive Stock Picks with Upside - Newser
When is Lyra Therapeutics Inc. stock expected to show significant growthOutstanding growth strategies - jammulinksnews.com
Competitive Positioning of Lyra Therapeutics Inc.: Is It Leading or LaggingFree Trading Strategy Suggestions - Newser
Should I hold or sell Lyra Therapeutics Inc. stock in 2025Invest like a pro with expert recommendations - jammulinksnews.com
Buy Signal for Lyra Therapeutics Inc. Stock Key Technical Indicators to WatchLong Term Secure Gain Stocks - Newser
Has Lyra Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewTop Analyst Picks - Newser
How high can Lyra Therapeutics Inc. stock price go in 2025Free Bull & Bear Market Updates - jammulinksnews.com
Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional
What drives Lyra Therapeutics Inc. stock priceConsistent wealth multiplication - jammulinksnews.com
Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional
Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus
How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser
Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):